Iovance Biotherapeutics Inc (IOVA)
8.88
-0.12
(-1.33%)
USD |
NASDAQ |
May 31, 16:00
8.89
+0.01
(+0.11%)
Pre-Market: 20:00
Iovance Biotherapeutics Total Assets (Quarterly): 869.83M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 869.83M |
December 31, 2023 | 780.35M |
September 30, 2023 | 852.32M |
June 30, 2023 | 757.29M |
March 31, 2023 | 824.77M |
December 31, 2022 | 663.98M |
September 30, 2022 | 545.92M |
June 30, 2022 | 610.88M |
March 31, 2022 | 701.25M |
December 31, 2021 | 777.33M |
September 30, 2021 | 828.82M |
June 30, 2021 | 852.79M |
March 31, 2021 | 750.57M |
December 31, 2020 | 768.46M |
September 30, 2020 | 782.29M |
June 30, 2020 | 817.57M |
March 31, 2020 | 288.30M |
December 31, 2019 | 344.66M |
September 30, 2019 | 395.75M |
June 30, 2019 | 435.92M |
March 31, 2019 | 461.50M |
December 31, 2018 | 480.82M |
September 30, 2018 | 270.83M |
June 30, 2018 | 284.75M |
March 31, 2018 | 307.25M |
Date | Value |
---|---|
December 31, 2017 | 155.37M |
September 30, 2017 | 173.97M |
June 30, 2017 | 138.01M |
March 31, 2017 | 155.39M |
December 31, 2016 | 171.89M |
September 30, 2016 | 182.32M |
June 30, 2016 | 193.54M |
March 31, 2016 | 100.77M |
December 31, 2015 | 105.65M |
September 30, 2015 | 112.22M |
June 30, 2015 | 114.74M |
March 31, 2015 | 113.54M |
December 31, 2014 | 46.51M |
September 30, 2014 | 17.42M |
June 30, 2014 | 18.54M |
March 31, 2014 | 18.08M |
December 31, 2013 | 19.87M |
September 30, 2013 | 0.1686M |
June 30, 2013 | 0.5977M |
March 31, 2013 | 0.0283M |
December 31, 2012 | 0.0294M |
September 30, 2012 | 0.0287M |
June 30, 2012 | 0.0656M |
March 31, 2012 | 0.0768M |
December 31, 2011 | 0.5684M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
288.30M
Minimum
Mar 2020
869.83M
Maximum
Mar 2024
682.45M
Average
762.88M
Median
Total Assets (Quarterly) Benchmarks
Viatris Inc | 47.34B |
Beam Therapeutics Inc | 1.360B |
Revolution Medicines Inc | 1.908B |
Day One Biopharmaceuticals Inc | 326.64M |
Viking Therapeutics Inc | 967.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 189.81M |
Shareholders Equity (Quarterly) | 680.02M |
Debt to Equity Ratio | 0.0015 |
Current Ratio | 4.633 |